Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.

2.50
Hdl Handle:
http://hdl.handle.net/11287/620205
Title:
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.
Authors:
Vogelmeier, C. F.; Criner, G. J.; Martinez, F. J.; Anzueto, A.; Barnes, P. J.; Bourbeau, J.; Celli, B. R.; Chen, R.; Decramer, M.; Fabbri, L. M.; Frith, P.; Halpin, David M; López Varela, M. V.; Nishimura, M.; Roche, N.; Rodriguez-Roisin, R.; Sin, D. D.; Singh, D.; Stockley, R.; Vestbo, J.; Wedzicha, J. A.; Agusti, A.
Abstract:
This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention of COPD (GOLD) 2017 Report focuses primarily on the revised and novel parts of the document. The most significant changes include: i) the assessment of COPD has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; ii) for each of the groups A to D, escalation strategies for pharmacological treatments are proposed; iii) the concept of de-escalation of therapy is introduced in the treatment assessment scheme; iv) nonpharmacologic therapies are comprehensively presented and; v) the importance of comorbid conditions in managing COPD is reviewed.
Citation:
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary. 2017 Am. J. Respir. Crit. Care Med.
Publisher:
AJRCCM
Journal:
American journal of respiratory and critical care medicine
Issue Date:
27-Jan-2017
URI:
http://hdl.handle.net/11287/620205
DOI:
10.1164/rccm.201701-0218PP
PubMed ID:
28128970
Additional Links:
http://www.atsjournals.org/doi/abs/10.1164/rccm.201701-0218PP?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Type:
Journal Article; Guideline
Language:
en
ISSN:
1535-4970
Appears in Collections:
Respiratory Medicine; 2017 RD&E publications

Full metadata record

DC FieldValue Language
dc.contributor.authorVogelmeier, C. F.en
dc.contributor.authorCriner, G. J.en
dc.contributor.authorMartinez, F. J.en
dc.contributor.authorAnzueto, A.en
dc.contributor.authorBarnes, P. J.en
dc.contributor.authorBourbeau, J.en
dc.contributor.authorCelli, B. R.en
dc.contributor.authorChen, R.en
dc.contributor.authorDecramer, M.en
dc.contributor.authorFabbri, L. M.en
dc.contributor.authorFrith, P.en
dc.contributor.authorHalpin, David Men
dc.contributor.authorLópez Varela, M. V.en
dc.contributor.authorNishimura, M.en
dc.contributor.authorRoche, N.en
dc.contributor.authorRodriguez-Roisin, R.en
dc.contributor.authorSin, D. D.en
dc.contributor.authorSingh, D.en
dc.contributor.authorStockley, R.en
dc.contributor.authorVestbo, J.en
dc.contributor.authorWedzicha, J. A.en
dc.contributor.authorAgusti, A.en
dc.date.accessioned2017-02-01T15:18:44Z-
dc.date.available2017-02-01T15:18:44Z-
dc.date.issued2017-01-27-
dc.identifier.citationGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary. 2017 Am. J. Respir. Crit. Care Med.en
dc.identifier.issn1535-4970-
dc.identifier.pmid28128970-
dc.identifier.doi10.1164/rccm.201701-0218PP-
dc.identifier.urihttp://hdl.handle.net/11287/620205-
dc.description.abstractThis Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention of COPD (GOLD) 2017 Report focuses primarily on the revised and novel parts of the document. The most significant changes include: i) the assessment of COPD has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; ii) for each of the groups A to D, escalation strategies for pharmacological treatments are proposed; iii) the concept of de-escalation of therapy is introduced in the treatment assessment scheme; iv) nonpharmacologic therapies are comprehensively presented and; v) the importance of comorbid conditions in managing COPD is reviewed.en
dc.language.isoenen
dc.publisherAJRCCMen
dc.relation.urlhttp://www.atsjournals.org/doi/abs/10.1164/rccm.201701-0218PP?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmeden
dc.rightsArchived with thanks to American journal of respiratory and critical care medicineen
dc.subjectWessex Classification Subject Headings::Respiratory medicineen
dc.titleGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.en
dc.typeJournal Articleen
dc.typeGuidelineen
dc.identifier.journalAmerican journal of respiratory and critical care medicineen
dc.type.versionIn press (epub ahead of print)en

Related articles on PubMed

All Items in RD&E Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.